( November 11, 2025, 11:50 AM EST) -- CAMDEN, N.J. — The first bellwether case in the valsartan,
XE "valsartan" losartan and
XE "losartan" irbesartan
XE "irbesartan" hypertension drugs multidistrict litigation was dismissed with prejudice on Nov. 10 after the New Jersey federal judge overseeing the MDL found that testimony from the plaintiff’s expert that ruled out other causes of a man’s liver cancer was “nothing more than speculative ipse dixit.”...